Charles Theuer insider trades: Tracon Pharmaceuticals (TCON) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
41 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 27, 2023 | TCON | ↑ Buy | 50,999 | $0.74 | $38K | Direct | Apr 28, 2023 (1d) |
| Mar 1, 2023 | TCON | ↑ Buy | 5,000 | $1.52 | $8K | Direct | Mar 2, 2023 (1d) |
| Jan 18, 2023 | TCON | ↑ Buy | 6,800 | $1.62 | $11K | Direct | Jan 19, 2023 (1d) |
| Dec 14, 2022 | TCON | ↑ Buy | 23,000 | $1.29 | $30K | Direct | Dec 15, 2022 (1d) |
| Nov 18, 2022 | TCON | ↑ Buy | 13,900 | $1.41 | $20K | Direct | Nov 22, 2022 (4d) |
| Nov 3, 2022 | TCON | ↑ Buy | 9,200 | $1.52 | $14K | Direct | Nov 4, 2022 (1d) |
| Nov 2, 2022 | TCON | ↑ Buy | 6,000 | $1.59 | $10K | Direct | Nov 3, 2022 (1d) |
| Oct 7, 2022 | TCON | ↑ Buy | 5,000 | $1.77 | $9K | Direct | Oct 11, 2022 (4d) |
| Oct 3, 2022 | TCON | ↑ Buy | 5,000 | $1.67 | $8K | Direct | Oct 5, 2022 (2d) |
| Sep 22, 2022 | TCON | ↑ Buy | 5,000 | $1.76 | $9K | Direct | Sep 26, 2022 (4d) |
| Jul 22, 2022 | TCON | ↑ Buy | 4,500 | $1.85 | $8K | Direct | Jul 25, 2022 (3d) |
| Jul 13, 2022 | TCON | ↑ Buy | 6,000 | $1.85 | $11K | Direct | Jul 14, 2022 (1d) |
| May 9, 2022 | TCON | ↑ Buy | 10,000 | $1.85 | $19K | Direct | May 11, 2022 (2d) |
| May 6, 2022 | TCON | ↑ Buy | 2,500 | $1.97 | $5K | Direct | May 10, 2022 (4d) |
| Apr 29, 2022 | TCON | ↑ Buy | 5,000 | $1.97 | $10K | Direct | May 3, 2022 (4d) |
| Apr 21, 2022 | TCON | ↑ Buy | 4,500 | $2.30 | $10K | Direct | Apr 25, 2022 (4d) |
| Apr 8, 2022 | TCON | ↑ Buy | 2,000 | $2.50 | $5K | Direct | Apr 12, 2022 (4d) |
| Mar 30, 2022 | TCON | ↑ Buy | 4,000 | $2.70 | $11K | Direct | Apr 1, 2022 (2d) |
| Mar 21, 2022 | TCON | ↑ Buy | 1,200 | $2.45 | $3K | Direct | Mar 23, 2022 (2d) |
| Nov 19, 2021 | TCON | ↑ Buy | 4,181 | $2.83 | $12K | Direct | Nov 22, 2021 (3d) |
| Nov 5, 2021 | TCON | ↑ Buy | 4,000 | $3.41 | $14K | Direct | Nov 9, 2021 (4d) |
| Aug 16, 2021 | TCON | ↑ Buy | 3,000 | $3.56 | $11K | Direct | Aug 18, 2021 (2d) |
| Jan 27, 2021 | TCON | ↑ Buy | 11,000 | $8.98 | $99K | Direct | Jan 28, 2021 (1d) |
| Dec 29, 2020 | TCON | ↑ Buy | 1,000 | $9.98 | $10K | Direct | Dec 30, 2020 (1d) |
| Oct 21, 2020 | TCON | ↑ Buy | 2,000 | $4.38 | $9K | Direct | Oct 23, 2020 (2d) |
| Sep 23, 2020 | TCON | ↑ Buy | 5,000 | $4.72 | $24K | Direct | Sep 25, 2020 (2d) |
| Sep 4, 2020 | TCON | ↑ Buy | 10,000 | $2.58 | $26K | Direct | Sep 9, 2020 (5d) |
| Aug 21, 2020 | TCON | ↑ Buy | 5,325 | $1.56 | $8K | Direct | Aug 25, 2020 (4d) |
| Aug 20, 2020 | TCON | ↑ Buy | 30,000 | $1.58 | $47K | Direct | Aug 24, 2020 (4d) |
| Aug 18, 2020 | TCON | ↑ Buy | 44,843 | $1.63 | $73K | Direct | Aug 18, 2020 (0d) |
| Aug 13, 2020 | TCON | ↑ Buy | 20,000 | $1.73 | $35K | Direct | Aug 14, 2020 (1d) |
| Jun 24, 2020 | TCON | ↑ Buy | 9,895 | $1.90 | $19K | Direct | Jun 25, 2020 (1d) |
| May 22, 2020 | TCON | ↑ Buy | 10,592 | $1.90 | $20K | Direct | May 26, 2020 (4d) |
| Mar 13, 2020 | TCON | ↑ Buy | 4,100 | $1.13 | $5K | Direct | Mar 13, 2020 (0d) |
| Mar 12, 2020 | TCON | ↑ Buy | 20,000 | $1.43 | $29K | Direct | Mar 12, 2020 (0d) |
| Mar 10, 2020 | TCON | ↑ Buy | 10,000 | $1.87 | $19K | Direct | Mar 10, 2020 (0d) |
| Aug 9, 2019 | TCON | ↑ Buy | 50,000 | $0.45 | $23K | Direct | Aug 12, 2019 (3d) |
| Dec 21, 2018 | TCON | ↑ Buy | 49,000 | $0.66 | $32K | Direct | Dec 21, 2018 (0d) |
| Sep 18, 2015 | TCON | ↓ Sell | 10,000 | $17.34 | $173K | Direct | Sep 22, 2015 (4d) |
| Sep 10, 2015 | TCON | ↓ Sell | 3,516 | $12.00 | $42K | Direct | Sep 14, 2015 (4d) |
| Aug 14, 2015 | TCON | ↓ Sell | 100 | $12.00 | $1K | Direct | Aug 18, 2015 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Charles Theuer's insider trades
Charles Theuer is President and CEO at Tracon Pharmaceuticals (TCON). Since Aug 14, 2015, Charles has reported 38 open-market purchases worth $749K and 3 sales worth $217K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), shares withheld for taxes (4 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TCON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.